探究冠心病遗传特征:心肌灌注显像技术是否有一席之地?
本文综述冠心病遗传因素与环境因素的相互作用,指出全基因组关联研究已识别多个单核苷酸多态性但分子因果证据不足。心肌SPECT与PET可直接评估心肌灌注及血管/内皮功能障碍,或有助于探究易感变异的功能后果并在高遗传风险人群中早期发现亚临床异常。
要点
- 多数冠心病相关多态性位于非蛋白编码区,分子因果证据有限。
- 心肌SPECT/PET可评估灌注及血管/内皮功能障碍,助力机制研究。
- 遗传信息联合功能显像或优化高遗传风险人群的筛查与决策。
核心结论
- 遗传信息可识别冠心病长期高遗传风险人群,心肌SPECT或PET功能显像有望通过早期描绘亚临床功能障碍来探究易感变异的分子因果并辅助临床决策。
研究设计与样本
- 本文为综述,围绕冠心病遗传特征与心肌灌注显像技术的关系进行论述。
主要发现
- 全基因组关联研究已识别多个单核苷酸多态性,但缺乏强分子因果证据。
- 少数报道的易感变异与冠心病传统危险因素相关,多数多态性位于DNA非蛋白编码区。
- SPECT和PET已用于研究多个冠心病相关多态性的功能后果及他汀类治疗反应。
临床怎么用
- 在高遗传风险人群中,心肌SPECT或PET可在动脉粥样硬化标志物可识别之前早期发现亚临床功能障碍。
- 临床可将遗传证据与心肌SPECT或PET功能显像结合,以形成更高效筛查方法并改善诊断检查与患者管理决策。
局限性
- 原文指出冠心病遗传架构仍很不清楚,且缺乏强分子因果证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several environmental and genetic factors have been found to influence the development and progression of coronary artery disease (CAD). Although the effects of the environmental hazards on CAD pathophysiology are well documented, the genetic architecture of the disease remains quite unclear. A number of single-nucleotide polymorphisms have been identified based on the results of the genome-wide association studies. However, there is a lack of strong evidence regarding molecular causality. The minority of the reported predisposing variants can be related to the conventional risk factors of CAD, while most of the polymorphisms occur in non-protein-coding regions of the DNA. However, independently of the specific underlying mechanisms, genetic information could lead to the identification of a population at higher genetic risk for the long-term development of CAD. Myocardial single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are functional imaging techniques that can evaluate directly myocardial perfusion, and detect vascular and/or endothelial dysfunction. Therefore, these techniques could have a role in the investigation of the underlying mechanisms associated with the identified predisposing variants, advancing our understanding regarding molecular causality. In the population at higher genetic risk, myocardial SPECT or PET could provide important evidence through the early depiction of sub-clinical dysfunctions, well before any atherosclerosis marker could be identified. Notably, SPECT and PET techniques have been already used for the investigation of the functional consequences of several CAD-related polymorphisms, as well as the response to certain treatments (statins). Furthermore, therefore, in the clinical setting, the combination of genetic evidence with the findings of myocardial SPECT, or PET, functional imaging techniques could lead to more efficient screening methods and may improve decision making with regard to the diagnostic investigation and patients' management.
引用
- Angelidis G, Valotassiou V, Satra M, et al. Investigating the genetic characteristics of CAD: Is there a role for myocardial perfusion imaging techniques? J Nucl Cardiol. 2020. PMID: 33141407. doi:10.1007/s12350-020-02403-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。